メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
医学部・血液内科学
藤田医科大学
医学部
概要
フィンガープリント
ネットワーク
プロファイル
(5)
研究成果
(48)
フィンガープリント
医学部・血液内科学が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
D-index
44%
Leukemia Cells
40%
Subgroup Analysis
40%
Rolling Adhesion
40%
Dynamic Analysis
40%
ILC2
40%
Differentiation Syndrome
40%
Third Harmonic Generation
40%
Nonlinear Optics
40%
Near-infrared Excitation
40%
Real-time Quantitative
40%
Second Harmonic Generation
40%
Febrile Neutropenia
40%
Multiphoton Excitation Microscopy
40%
Non-labeling
40%
Ravulizumab
40%
Cardiopulmonary Arrest
40%
Macrophage Targeting
40%
Dexamethasone Palmitate
40%
Gastroduodenitis
40%
Pure Red Cell Aplasia
40%
Deferasirox
40%
Mature Osteoblasts
40%
Chemoresistant
40%
Proton Density Fat Fraction
40%
Clasp
40%
Focal Adhesion Disassembly
40%
Promyelocytic Leukemia Zinc Finger
40%
VR-CAP
40%
Mantle Cell Lymphoma
40%
Cytarabine
40%
Antifungal Therapy
40%
Biomarker Monitoring
40%
Fungal Biomarkers
40%
Invasive Fungal Disease
40%
Micafungin
40%
Prognostic Implications
40%
NPM1 mutation
40%
Cell-mediated
40%
In Vivo Live Imaging
40%
Steno
40%
Hypoplastic Myelodysplastic Syndrome
40%
Randomized Controlled Non-inferiority Trial
40%
Molecular Landscape
40%
Acute Myeloid Leukemia
26%
Early Molecular Response
26%
Motility
26%
Bone Marrow
26%
In Situ Behaviour
26%
Chemoresistance
26%
Duodenal Fistula
20%
Bone Research
20%
Life Phenomena
20%
Dynamic Behavior
20%
Multiphoton Imaging
20%
Thin Sectioning
20%
Specific Mode
20%
Mineral Research
20%
Optical Imaging Technology
20%
Risk Treatment
17%
High Risk
17%
Therapy Groups
17%
Small Intestine
16%
Dexamethasone Sodium Phosphate
16%
Chemotherapy
13%
Migration Potential
13%
Intravital Two-photon Imaging
13%
Minodronate
13%
Acute Myeloid Leukemia Cells
13%
Cell Migration
13%
Mouse Model
13%
Second-generation Tyrosine Kinase Inhibitors
13%
Dasatinib
13%
BCR-ABL1
13%
Vascular Adverse Events
13%
Bone Scan
13%
Antitumor Effect
13%
Dormant
13%
Cell Motility
13%
RNA Sequencing (RNA-seq)
13%
Extended Period
13%
Therapeutic Target
13%
Chemotherapy-induced
13%
Leukemia Mice
13%
Anti-cytomegalovirus Activity
13%
Pathway Activation
13%
Gastric Folds
13%
Detailed Methodology
13%
Cellular Dynamics
13%
Dynamic Cells
13%
Chemotherapy Resistance
13%
Intravital 2-photon Microscopy
13%
Intact Organs
13%
Conventional Methodologies
13%
Functional Coupling
13%
Dynamic Phenomena
13%
Bone Cavity
13%
Deep Learning Analysis
13%
Turnaround Time
13%
Non-invasive Diagnosis
13%
Medicine and Dentistry
Leukemia Cell
100%
Febrile Neutropenia
80%
Imaging of Bone
80%
Imaging Technique
60%
Drug Resistance
60%
Two-Photon Microscopy
53%
Myelodysplastic Syndrome
46%
Factor Analysis
45%
Cytarabine
43%
Acute Myeloid Leukemia
40%
Bleeding
40%
Subgroup Analysis
40%
Mantle Cell Lymphoma
40%
Myeloid Leukemia
40%
Duodenum Ulcer
40%
Bone Marrow Microenvironment
40%
Hematopoietic Stem Cell
40%
Bloodstream Infection
40%
Fibroblast Growth Factor 2
40%
Acute Promyelocytic Leukemia
40%
Multiphoton Microscopy
40%
Ravulizumab
40%
Vertebra
40%
Clinical Study
40%
Azacitidine
40%
Deferasirox
40%
Pure Red Cell Aplasia
40%
Cardiopulmonary Arrest
40%
Post-Hoc Analysis
40%
Antifungal Therapy
40%
Bone Tissue
40%
Micafungin
40%
NPM1
40%
Osteoblast
40%
Leukemia
31%
Bevacizumab
30%
Cell Interaction
20%
Cell Motion
20%
Aplastic Anemia
20%
Drug Withdrawal
20%
Fistula
20%
Supportive Care
18%
Abdominal Pain
18%
Group Therapy
17%
Spontaneous Remission
17%
Antiinfective Agent
15%
Refractory Anemia with Excess of Blasts
14%
Flavine Adenine Nucleotide
13%
Cytomegalovirus Antibody
13%
Cervix Uteri
13%
Clinical Trial
12%
Overall Survival
11%
Leukocyte
11%
Paxillin
11%
Complement Inhibitor
11%
Cell Count
11%
Body Surface
11%
Anticoagulant
11%
Neoplasm
10%
Dasatinib
10%
Nilotinib
10%
Base
10%
Antiulcer Agent
10%
Malignant Neoplasm
10%
Breast Cancer
10%
Minodronic Acid
10%
Ulcer
10%
Nonsteroid Antiinflammatory Agent
10%
Vasculotropin Antibody
10%
Blood Culture
10%
Fifth Disease
10%
Refractory Anemia
10%
Parvovirus B19
10%
Cell Motility
10%
RNA Sequence
10%
Common Bile Duct
10%
Cholangiography
10%
Bile
10%
Melena
10%
Cell Migration
10%
Symptom
8%
Acute Heart Infarction
8%
Mucosa
8%
Ileum
8%
Small Intestine Resection
8%
Testicular Enlargement
8%
Endoscopy
8%
Stenosis
8%
Recurrent Fever
8%
Balloon Dilatation
8%
Antiviral Drug
8%
Stromal Cell
6%
Sensitivity and Specificity
6%
Cell Growth
6%
McNemar Test
6%
Hematopoiesis
6%
Tetramer
6%
Restriction Fragment Length Polymorphism
6%
Arginine
6%
Proline
6%
Pharmacology, Toxicology and Pharmaceutical Science
Febrile Neutropenia
80%
Malignant Neoplasm
50%
Leukemia
48%
Chemotherapy
43%
Acute Myeloid Leukemia
40%
Mantle Cell Lymphoma
40%
Myelodysplastic Syndrome
40%
Biological Marker
40%
Colorectal Cancer
40%
Bleeding
40%
Pharmacokinetics
40%
Two-Photon Microscopy
40%
Piperacillin Plus Tazobactam
40%
Bloodstream Infection
40%
Hospital Infection
40%
Promyelocytic Leukemia
40%
Syndrome
40%
Micafungin
40%
Antifungal Therapy
40%
Ravulizumab
40%
Paroxysmal Nocturnal Hemoglobinuria
40%
Seminoma
40%
Azacitidine
40%
Mycosis
40%
Community Acquired Infection
40%
Antiinflammatory Activity
40%
Zinc Finger and BTB Domain Containing Protein 16
40%
Retinoic Acid Receptor
40%
Promyelocytic Leukemia Protein
40%
Thrombomodulin
40%
Clinical Study
40%
Piperacillin
32%
Cytarabine
30%
Remission
22%
Drug Resistance
20%
Recombinant Thrombomodulin
20%
Haematoxylin
20%
Eosin
20%
Flavine Adenine Nucleotide
20%
Nicotinamide Adenine Dinucleotide
20%
Nicotinamide Adenine Dinucleotide Phosphate
20%
Infection
16%
Galactomannan
16%
Glucan
16%
Recurrent Fever
16%
Bacterial Infection
16%
Antiinfective Agent
15%
Refractory Anemia with Excess Blasts
14%
Dexamethasone Sodium Phosphate
13%
Mouse
13%
Clinical Trial
12%
Overall Survival
11%
Complement Inhibitor
11%
Anticoagulant Agent
11%
Neoplasm
10%
Minodronic Acid
10%
Proton Pump
10%
Mouse Model
10%
Dasatinib
10%
RNA-Sequencing
10%
Bone Marrow Depression
8%
Urinary Tract Infection
8%
Respiratory Tract Infection
8%
Respiratory Tract
8%
NONMEM
8%
Normal Human
8%
Testicular Enlargement
8%
Infectious Agent
8%
Aspergillus
8%
Antibacterial Therapy
8%
Pharmacokinetic Parameter
8%
Antiviral Drug
8%
Refractory Anemia with Excess Blasts in Transformation
7%
Inflammation
6%
Lectin
6%
Lipopolysaccharide
6%
Membrane Protein
6%
Disease Free Survival
5%
Acute Leukemia
5%
Neutropenia
5%
Oncoprotein
5%
Eculizumab
5%
Leukocytosis
5%
Retinoic Acid
5%
Hematologic Malignancy
5%
Infection Complication
5%
Gram Negative Sepsis
5%
Gram Negative Bacterium
5%
Hypotension
5%